Doctors have been calling for an RSV vaccine for seniors because although the virus is common, older people are much more likely to become severely ill and require hospitalization.
Opvee is similar to naloxone, the life-saving drug that has been used for decades to quickly counter overdoses of heroin, fentanyl and prescription painkillers.
Access to the new monoclonal antibody for prophylactic treatment will probably be tightly controlled, but parents may ask for it after an early RSV season last year.
The U.S. Food and Drug Administration decision makes GSK’s shot, called Arexvy, the first of several potential vaccines in the pipeline for RSV to be licensed anywhere.
The timing of this year's Cross-Border Crime Forum is still unconfirmed, but U.S. Attorney General Merrick Garland and Homeland Security Secretary Alejandro Mayorkas are expected to attend.
